Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:30 pm Purchase |
2024-12-31 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA |
BERNS PAUL L | 8,226,272 5.100% |
242,125 (+3.03%) |
Filing History |
| 2024-11-22 5:33 pm Purchase |
2024-11-12 | 13D | Neumora Therapeutics, Inc. Common Stock NMRA |
ARCH Venture Fund XII, L.P. | 31,979,111 19.800% |
12,904 (+0.04%) |
Filing History |
| 2024-11-12 4:30 pm Sale |
2024-09-30 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA |
SoftBank Group Corp. | 7,546,916 4.700% |
-100,000 (-1.31%) |
Filing History |
| 2024-07-08 4:15 pm Unchanged |
2024-06-28 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA |
FMR CORP | 8,622,468 5.400% |
0 (Unchanged) |
Filing History |
| 2024-07-08 1:07 pm Purchase |
2024-06-28 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA |
FMR CORP | 8,622,468 5.400% |
8,622,468 (New Position) |
Filing History |
| 2024-02-14 4:17 pm Purchase |
2023-12-31 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA |
BERNS PAUL L | 7,984,147 5.200% |
7,984,147 (New Position) |
Filing History |
| 2024-02-13 5:00 pm Purchase |
2023-12-31 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA |
SoftBank Group Corp. | 7,646,916 5.000% |
7,646,916 (New Position) |
Filing History |
| 2023-12-15 5:06 pm Purchase |
2023-12-08 | 13D | Neumora Therapeutics, Inc. Common Stock NMRA |
ARCH Venture Fund XII, L.P. | 31,966,207 20.900% |
2,168,831 (+7.28%) |
Filing History |
| 2023-09-29 8:22 pm Purchase |
2023-09-19 | 13D | Neumora Therapeutics, Inc. Common Stock NMRA |
ARCH Venture Fund XII, L.P. | 29,797,376 19.600% |
29,797,376 (New Position) |
Filing History |
| 2023-09-27 07:30 am Purchase |
2023-09-19 | 13D | Neumora Therapeutics, Inc. Common Stock NMRA |
AMGEN INC AMGN |
35,368,653 23.200% |
35,368,653 (New Position) |
Filing History |